Primecap Management
KBIO

Primecap Management’s KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) KBIO Stock Holding History

Primecap Management’s Portfolio KBIO Stock Details KBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-534,885
Closed -$1.02M – 278
2015
Q3 		$1.02M Sell
534,885
-6,065
-1% -$16K ﹤0.01% 269
2015
Q2 		$2.08M Sell
540,950
-3,088
-0.6% -$13.1K ﹤0.01% 248
2015
Q1 		$2.13M Sell
544,038
-15,425
-3% -$69.2K ﹤0.01% 246
2014
Q4 		$7.74M Hold
559,463
– – 0.01% 227
2014
Q3 		$6.94M Hold
559,463
– – 0.01% 225
2014
Q2 		$10.2M Sell
559,463
-26,971
-5% -$462K 0.01% 212
2014
Q1 		$12.7M Sell
586,434
-1,063
-0.2% -$30.8K 0.01% 205
2013
Q4 		$20.8M Sell
587,497
-837
-0.1% -$28K 0.03% 193
2013
Q3 		$21.3M Buy
588,334
+128,125
+28% +$5.84M 0.03% 187
2013
Q2 		$20.8M Buy
+460,209
New +$20.9M 0.03% 184

Other funds holding KBIO

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $50.9B AUM 42.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $564B AUM 30.12% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return